NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Vanina Rodríguez
Garvan Institute of Medical Research - Darlinghurst / Australia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4379477
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Vanina Rodríguez's MOST POPULAR ARTICLES
1-)
Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphomaA Moros, V Rodriguez, I Saborit-Villarroya, A Montraveta, P Balsas, ...Leukemia 28 (10), 2049, 20141052014
2-)
Development of a novel anti-CD19 chimeric antigen receptor: a paradigm for an affordable CAR T cell production at academic institutionsM Castella, A Boronat, R Martín-Ibáñez, V Rodríguez, G Suñé, ...Molecular Therapy-Methods & Clinical Development 12, 134-144, 20191062019
3-)
The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphomaA Esteve-Arenys, JG Valero, A Chamorro-Jorganes, D Gonzalez, ...Oncogene, 1, 2018892018
4-)
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemiaS Xargay-Torrent, M López-Guerra, L Rosich, A Montraveta, J Roldán, ...Oncotarget 6 (26), 22734, 2015752015
5-)
Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugsGD Peluffo, I Stillitani, VA Rodríguez, MJ Diament, SM KleinInternational journal of cancer 110 (6), 825-830, 2004672004
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept